Find information on how we’re keeping you safe from COVID-19 here

To top

Areas of Expertise

Conditions that Professor Ailsa Hart commonly treats for, include:

  • Inflammatory Bowel Disease
  • Irritable Bowel Syndrome
  • Abdominal pain
  • Abdominal bloating
  • Diarrhoea


Professor Ailsa Hart is an experienced gastroenterologist who performs:

  • Colonoscopy
  • Gastroscopy


Career Highlights

Professor Ailsa Hart, BMBCh, FRCP, PhD is a Consultant Gastroenterologist at St Mark’s Hospital and Dean of St Mark’s Academic Institiute. She studied medicine at Oxford University and was awarded a First-Class Honours Degree. She achieved her PhD with Imperial College London, funded by a Wellcome Trust Fellowship, and in 2016, she achieved academic promotion at Imperial College London, UK, and is now Professor of Practice. She is also Honorary Skou Professor at the University of Aarhus in Denmark. She has mentored and trained many gastroenterologists, who are now engaged in IBD management nationally and internationally. Together with many of them, she has published 2 books and over 280 papers, reviews and book chapters. She is currently on the Governing Board of the European Crohn’s and Colitis Organisation (ECCO) as Scientific Officer and was past Treasurer and member of the Clinical Committee of ECCO. She is on the IBD Clinical Research Group Committee for the British Society of Gastroenterology (BSG) and past Chair of the Gut Microbiota for Health Group of the BSG. She is the UK Patient and Public Involvement Lead for Gastroenterology and is on the Research Committee for the Crohn’s and Colitis UK charity. She is a member of the International Organization for the Study of Inflammatory Bowel Disease (IOIBD).


She has published extensively  in the field of inflammatory bowel disease. She has published over 280 papers and 2 books on the topic of inflammatory bowel disease. She has pioneered faecal microbiota transplantation, and has particular expertise in patients with perianal Crohn’s disease, ileo-anal pouch anastomoses and IBD cancer surveillance.